ILOILO CITY — A health and wellness company is positioning itself in the growing regenerative medicine market with the introduction of a plant-based stem cell therapy product developed through international collaboration and local manufacturing.
MaxCortec Global said its stem cell technology uses plant-derived cells sourced from Mibelle Biochemistry in Switzerland, utilizing PhytoCellTec technology to cultivate active stem cells under controlled conditions. The cells are grown in bioreactors to achieve high concentrations intended for therapeutic applications.
The company noted that the technology has been recognized as a “novel food” by the European Food Safety Authority, reflecting increasing global interest in plant-based regenerative solutions.
Finished products are formulated and encapsulated at the firm’s manufacturing facility in Tarlac, highlighting a model that combines imported biotechnology inputs with domestic production.
Marketed as MaxCortec Stem Cell Therapy, the product is being introduced as part of a broader push into preventive and regenerative healthcare, an industry segment that has seen rising demand amid interest in anti-aging, wellness, and chronic disease management.
Company representatives said the therapy is designed to support tissue repair, reduce inflammation, and improve overall vitality, with applications ranging from joint health to skin care and cardiovascular support.
Among the claimed benefits are cartilage repair for degenerative conditions, enhanced cellular regeneration, and improved collagen production. The product also targets hair growth, immune modulation, and circulation.
MaxCortec is also marketing the product based on a combination of high-value ingredients, including plant stem cells derived from Uttwiler Spätlauber apple and Vitis vinifera (grape), both known for antioxidant properties.
Other components include nattokinase, an enzyme associated with blood flow support; astaxanthin, a potent antioxidant; phycocyanin from spirulina; marine collagen; and fulvic minerals aimed at enhancing nutrient absorption.
While regenerative therapies continue to attract commercial interest, experts note that claims related to stem cell treatments — particularly in supplement or wellness formats — remain subject to ongoing scientific validation and regulatory oversight.
As the sector evolves, companies entering the space are expected to navigate both consumer demand and stricter scrutiny on efficacy, safety, and marketing claims.
Contact Us:(+63) 994 943 9921 – (+63) 920 618 8380
